Comparison of Use of Propiverine at 45 mg and Combined Treatment of Propiverine 30 mg and Mirabegron in Patients with Overactive Bladder Who did not Benefit from Propiverine 30 mg Treatment

IF 0.1 Q4 MEDICINE, GENERAL & INTERNAL

Gazi Medical Journal Pub Date : 2024-04-01 DOI:10.12996/gmj.2023.3677

İrfan Şafak Barlas, Selamettin Demir

引用次数: 0

查看原文本刊更多论文

对未从普罗帕韦林 30 毫克治疗中获益的膀胱过度活动症患者使用普罗帕韦林 45 毫克与普罗帕韦林 30 毫克和米拉贝琼联合治疗的比较

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Gazi Medical Journal MEDICINE, GENERAL & INTERNAL-

CiteScore

0.30

自引率

0.00%

发文量

105

审稿时长

16 weeks

期刊介绍： Gazi Medical Journal is being published from 1990 four times annually. Gazi Medical Journal is an international journal presenting research results in all medical fields, with the aim of becoming the premier source of high quality research from Eastern Europe , Middle East and Asia. The Gazi Medical Journal is peer-reviewed and is published quarterly in paper and electronic version. The language of the Gazi Medical Journal is English and Turkish. Offerings include research articles, rapid communications, case reports, letters to the editor, meta-analyses and commentaries

文献相关原料

公司名称	产品信息	采购帮参考价格